Suppr超能文献

关节内注射灵长类化抗CD4:对耐药类风湿性膝关节的疗效。一项关节镜检查、磁共振成像和组织学的联合研究。

Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histology.

作者信息

Veale D J, Reece R J, Parsons W, Radjenovic A, O'Connor P J, Orgles C S, Berry E, Ridgway J P, Mason U, Boylston A W, Gibbon W, Emery P

机构信息

Rheumatology and Rehabilitation Research Unit, Leeds SmithKline Beecham Pharmaceuticals, Leeds LS3 9NZ, United Kingdom.

出版信息

Ann Rheum Dis. 1999 Jun;58(6):342-9. doi: 10.1136/ard.58.6.342.

Abstract

OBJECTIVES

CD4+ T cells sustain the chronic synovial inflammatory response in rheumatoid arthritis (RA). SB-210396/CE 9.1 is an anti-CD4 monoclonal antibody that has documented efficacy in RA when given intravenously. This study aimed to establish the safety and efficacy of the intra-articular administration of SB-210396/CE 9.1 compared with placebo, examining its mode of action using a combined imaging approach of arthroscopy, magnetic resonance imaging (MRI), and histology.

METHODS

Thirteen RA patients with active, resistant knee synovitis, were randomised to intra-articular injection of placebo (n=3), 0.4 mg (n=3) or 40 mg (n=7) of anti-CD4 after sequential dynamic gadolinium enhanced MRI, followed by same day arthroscopy and synovial membrane biopsy. Imaging and arthroscopic synovial membrane sampling were repeated at six weeks. This study used a unique region of interest (ROI) analysis mapping the MRI area analysed to the specific biopsy site identified arthroscopically, thus providing data for all three modalities at the same synovial membrane site.

RESULTS

12 patients completed the study (one placebo treated patient refused further MRI). Arthroscopic improvement was observed in 0 of 2 placebo patients but in 10 of 10 patients receiving active drug (>20% in 6 of 10). Improvement in MRI was consistently observed in all patients of the 40 mg group but not in the other two groups. A reduction in SM CD4+ score was noted in the 40 mg group and in the 0.4 mg group. Strong correlations both before and after treatment, were identified between the three imaging modalities. Intra-articular delivery of SB-210396/CE 9.1 was well tolerated.

CONCLUSIONS

SB-210396/CE 9.1 is safe when administered by intra-articular injection. A trend toward efficacy was found by coordinated MRI, arthroscopic, and histological imaging, not seen in the placebo group. The value of ROI analysis was demonstrated.

摘要

目的

CD4 + T细胞维持类风湿关节炎(RA)的慢性滑膜炎症反应。SB - 210396/CE 9.1是一种抗CD4单克隆抗体,静脉注射时已证明对RA有效。本研究旨在确定与安慰剂相比,关节腔内注射SB - 210396/CE 9.1的安全性和有效性,并使用关节镜检查、磁共振成像(MRI)和组织学的联合成像方法研究其作用方式。

方法

13例患有活动性、难治性膝关节滑膜炎的RA患者,在进行连续动态钆增强MRI后,随机接受关节腔内注射安慰剂(n = 3)、0.4 mg(n = 3)或40 mg(n = 7)抗CD4药物,随后在同一天进行关节镜检查和滑膜活检。在六周时重复进行成像和关节镜滑膜取样。本研究使用了一个独特的感兴趣区域(ROI)分析,将MRI分析区域映射到通过关节镜确定的特定活检部位,从而在同一滑膜部位提供所有三种模式的数据。

结果

12例患者完成了研究(1例接受安慰剂治疗的患者拒绝进一步的MRI检查)。2例接受安慰剂治疗的患者中0例关节镜检查有改善,但接受活性药物治疗的10例患者中有10例改善(10例中有6例改善>20%)。40 mg组的所有患者均持续观察到MRI改善,而其他两组未观察到。40 mg组和0.4 mg组的SM CD4 +评分降低。治疗前后,三种成像模式之间均发现有强相关性。关节腔内注射SB - 210396/CE 9.1耐受性良好。

结论

关节腔内注射SB - 210396/CE 9.1是安全的。通过协调的MRI、关节镜和组织学成像发现了一种疗效趋势,而安慰剂组未观察到。证明了ROI分析的价值。

相似文献

7
Knee arthroscopy after yttrium or osmic acid injection.
Arthroscopy. 1989;5(1):70-5. doi: 10.1016/0749-8063(89)90096-0.

引用本文的文献

3
[Rheumatoid arthritis of the hand : Part 2: Imaging].手部类风湿关节炎:第2部分:影像学
Radiologe. 2021 Apr;61(4):362-374. doi: 10.1007/s00117-021-00833-3. Epub 2021 Mar 16.
5
MRI of synovitis and joint fluid.MRI 检查滑膜炎症和关节积液。
J Magn Reson Imaging. 2019 Jun;49(6):1512-1527. doi: 10.1002/jmri.26618. Epub 2019 Jan 8.
8
Cellular and molecular perspectives in rheumatoid arthritis.类风湿关节炎的细胞和分子视角
Semin Immunopathol. 2017 Jun;39(4):343-354. doi: 10.1007/s00281-017-0633-1. Epub 2017 May 15.
9
Evidence-based knee injections for the management of arthritis.循证膝关节注射治疗关节炎。
Pain Med. 2012 Jun;13(6):740-53. doi: 10.1111/j.1526-4637.2012.01394.x. Epub 2012 May 23.

本文引用的文献

1
Expectation bias in rheumatoid arthritis clinical trials. The anti-CD4 monoclonal antibody experience.
Arthritis Rheum. 1996 Nov;39(11):1773-80. doi: 10.1002/art.1780391102.
2
Diagnostic arthroscopy.诊断性关节镜检查
Baillieres Clin Rheumatol. 1996 Aug;10(3):495-517. doi: 10.1016/s0950-3579(96)80046-x.
6
Needle arthroscopy.针式关节镜检查
Br J Rheumatol. 1995 Dec;34(12):1102-4. doi: 10.1093/rheumatology/34.12.1102.
8
Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis.
Arthritis Rheum. 1993 Oct;36(10):1375-9. doi: 10.1002/art.1780361008.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验